ICU Medical (ICUI) Q4 Earnings and Revenues Top Estimates

Group 1 - ICU Medical reported quarterly earnings of $2.11 per share, exceeding the Zacks Consensus Estimate of$ 1.48 per share, and up from $1.57 per share a year ago, representing an earnings surprise of 42.57% [1] - The company achieved revenues of$ 621.62 million for the quarter ended December 2024, surpassing the Zacks Consensus Estimate by 3.95%, and an increase from $587.86 million year-over-year [2] - Over the last four quarters, ICU Medical has consistently surpassed consensus EPS and revenue estimates [2] Group 2 - The stock has underperformed the market, losing about 0.6% since the beginning of the year compared to the S&P 500's gain of 1.3% [3] - The current consensus EPS estimate for the upcoming quarter is$ 1.14 on revenues of $569.1 million, and for the current fiscal year, it is$ 6.94 on revenues of $2.23 billion [7] - The Zacks Industry Rank indicates that the Medical - Products sector is in the bottom 49% of over 250 Zacks industries, which may impact stock performance [8] Group 3 - The estimate revisions trend for ICU Medical is mixed, resulting in a Zacks Rank 3 (Hold), suggesting the stock is expected to perform in line with the market in the near future [6] - Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5]